Comments on: Blogging my way into a Diabetic Coma http://www.americanbiotechnologist.com/blog/blogging-diabetic-coma/ Advancing the productivity of American Biotechnologists Mon, 20 May 2013 14:51:01 +0000 hourly 1 http://wordpress.org/?v=3.4.2 By: Dr. Eli Lewis http://www.americanbiotechnologist.com/blog/blogging-diabetic-coma/comment-page-1/#comment-468 Dr. Eli Lewis Tue, 08 Jun 2010 14:26:25 +0000 http://www.americanbiotechnologist.com/blog/?p=1151#comment-468 Dear subscribers, What timing! We have advanced quite a bit since some of the recent publications (for example in PNAS 2008). As expected, FDA had an easy track for approval of alpha-1-antitrypsin due to its impressive safety record, and after quite some time, which involved fine-tuning the clinical trials, I'm glad to share this press release, barely a day-old. http://www.marketwatch.com/story/omni-bio-announces-fda-ind-clearance-for-alpha-1-antitrypsin-aat-type-1-diabetes-clinical-trial-2010-06-08?reflink=MW_news_stmp I'll be glad to respond to comments! Dr. Eli Lewis, Ben-Gurion University of the Negev, Israel Dear subscribers,
What timing! We have advanced quite a bit since some of the recent publications (for example in PNAS 2008). As expected, FDA had an easy track for approval of alpha-1-antitrypsin due to its impressive safety record, and after quite some time, which involved fine-tuning the clinical trials, I’m glad to share this press release, barely a day-old.
http://www.marketwatch.com/story/omni-bio-announces-fda-ind-clearance-for-alpha-1-antitrypsin-aat-type-1-diabetes-clinical-trial-2010-06-08?reflink=MW_news_stmp

I’ll be glad to respond to comments!
Dr. Eli Lewis,
Ben-Gurion University of the Negev, Israel

]]>